The NPR Politics Podcast Abortion Access Could Be Limited Further By Mifepristone Case
Mar 16, 2023
Sarah McCammon, an NPR national correspondent specializing in abortion politics, delves into the contentious legal case surrounding mifepristone, the primary drug used in medication abortions. The discussion spans the implications of its FDA approval and the ongoing legal battles led by anti-abortion groups. Listeners learn about the potential for a Supreme Court showdown, the shifting political landscape regarding abortion rights post-Roe, and the societal perspectives on early abortion. It's a thought-provoking exploration of the future of abortion access in America.
AI Snips
Chapters
Transcript
Episode notes
Mifepristone Lawsuit
- A lawsuit challenges the FDA's 2000 approval of mifepristone, aiming to remove it from the market.
- This case has significant implications, as mifepristone is used in most medication abortions in the US.
Judge's Background
- Judge Matthew Kacsmaryk, a Trump appointee, is presiding over the case.
- He has a history of aligning with conservative and religious groups.
Lawsuit's Argument
- The lawsuit argues that the widespread availability of mifepristone undermines states' abortion restrictions.
- Plaintiffs claim doctors are harmed by providing follow-up care after medication abortions.